Deep dives for pharma professionals
Research, innovation and market-trend explainers — the context behind the headlines, written for people who work in the industry.
ResearchSenolytics and Microbiome Modifiers Two Quiet Levers Reshaping the Biology of Ageing
How senolytics and microbiome modifiers are reshaping ageing biology by targeting inflammation, senescence, and system-level decline.
20260212173840.webp&w=1920&q=75&dpl=dpl_9zbZE4bPoQgMoBcDfLZ1GxbdA4kv)
ResearchPsychedelic-Assisted Therapies: How Science Is Re-Exploring A Controversial Class Of Medicines
How psychedelic-assisted therapies are being re-explored to treat depression, PTSD, and addiction through science-led care.
20260127105020.webp&w=1920&q=75&dpl=dpl_9zbZE4bPoQgMoBcDfLZ1GxbdA4kv)
ResearchEngineered Microbes for APIs
How engineered microbes are quietly reshaping API manufacturing through biology, fermentation, and smarter, more resilient pharma production.
ResearchGVP Module VI: An Overview
A clear overview of GVP Module VI, explaining ICSR requirements, timelines, and EudraVigilance reporting in the EU.
ResearchGVP As A Growth Strategy: Turning Safety Data Into Competitive Advantage
How Good Pharmacovigilance Practices are evolving from compliance into a strategic growth and trust-building function in pharma.
ResearchAdvantages and Limitations of Non-Viral Delivery Systems
A strategic look at non-viral drug delivery systems, their advantages, limitations, and growing role in RNA, gene, and precision therapies.
ResearchFrom Human Inspection To Machine Vision: The Future Of AI-Powered Contamination Detection In Pharma
AI vision systems are reshaping pharma quality control by detecting contamination faster, improving consistency, and strengthening compliance.
ResearchThe Antibiotic Resistance: Zosurabalpin And The War On Superbugs
Zosurabalpin is a first-in-class antibiotic targeting Gram-negative superbugs and offering new hope against antimicrobial resistance.
ResearchAlzheimer’s Breakthrough Pipelines In The Pharmaceutical Industry
Alzheimer’s drug pipelines are evolving as amyloid antibodies, oral agents, and precision trials redefine disease-modifying strategies.
ResearchHow to Build a Contamination Control Strategy (CCS) That Works
Explore how CCS strengthens sterility, reduces deviations, and drives proactive contamination control in pharma.
ResearchBeyond One-Size-Fits-All: How Flow Chemistry And Targeted Delivery Are Shaping Personalized Medicine
Flow chemistry and smart delivery systems are redefining drug design, precision dosing, and personalized medicine.
ResearchDSIP: A Multifaceted Peptide with Intriguing Research Possibilities
Discover DSIP’s neuroprotective, stress-adaptive, and mitochondrial roles in research.